Back to search

Article

Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus

2020-03-18

Abstract excerpt

<h4>Objectives: </h4> Our previous research indicated the excellent in vitro antibacterial activity of Eravacycline (Erava) and its heteroresistance frequency against clinical Staphylococcus aureus isolates. In this study, we further aimed to investigate the Erava resistance and heteroresistance in S. aureus . <h4>Methods: </h4>: Eight parental S. aureus isolates were induced under Erava pressure in vitro and the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af3a08e1-2d30-5765-85a7-a43cb25590c7
DOI
10.21203/rs.3.rs-17893/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureusDOI 10.21203/rs.3.rs-17893/v1
Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus.Semantic proximity
In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolatesSemantic proximity
Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistanceSemantic proximity
In vitro Activity and Heteroresistance of Omadacycline Against Clinical Staphylococcus aureus Isolates From China Reveal the Impact of Omadacycline Susceptibility by Branched-Chain Amino Acid Transport System II Carrier Protein, Na/Pi Cotransporter Family Protein, and Fibronectin-Binding ProteinSemantic proximity
Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From ChinaSemantic proximity
Emerging strategies and therapeutic innovations for combating drug resistance in Staphylococcus aureus strains: A comprehensive reviewSemantic proximity
Study on drug susceptibility of Staphylococcus aureus and its correlation with virulence genesSemantic proximity
Tigecycline Resistance-Associated Mutations in the MepA Efflux Pump in Staphylococcus aureus.Semantic proximity
Genetic changes associated with tigecycline resistance in Staphylococcus aureus in vitro-selected mutants belonging to different lineages.Semantic proximity
The Y58D mutation in rpsJ gene is correlated with tigecycline and eravacycline combined resistance in ST80 vancomycin-resistant Enterococcus faecium isolates.Semantic proximity
Development of Resistance to Eravacycline by Klebsiella pneumoniae and Collateral Sensitivity-Guided Design of Combination TherapiesSemantic proximity
Bacteria antibiotic resistance: New challenges and opportunities for implant‐associated orthopedic infectionsSemantic proximity
Select a neighboring publication to make it the new centre.